Cancer Genetics (CGIX) Sees IPO Price in $11-$13/Share Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cancer Genetics (CGIX) Adjusts Expected IPO Price to $10 - $12/Share
March 4, 2013 10:35 AM ESTCancer Genetics (Nasdaq: CGIX) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The company plans to sell 1.85 million shares and sees an offering price of $10 to $12 per share. Prior expectations from the... More



